Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 01, 2021
Source ID
10.1016/j.isci.2021.102047

Entities

People

  • Anush Arakelyan
  • Barbara K. Felber
  • Brandon F. Keele
  • Celia C LaBranche
  • Claudia Cicala
  • Dai Fujikawa
  • David C. Montefiori
  • David J Venzon
  • Dominic Paquin Proulx
  • Donald Van Ryk
  • Eric Ni
  • Francesca Caccuri
  • Genoveffa Franchini
  • George N. Pavlakis
  • Georgia D. Tomaras
  • Giacomo Gorini
  • Guido Ferrari
  • Hung V. Trinh
  • Irene Kalisz
  • Isabela Silva De Castro
  • James Arthos
  • James D. Stamos
  • Jason J. Gorman
  • Jennifer Peele
  • Josh Kramer
  • Juliane Hill
  • Kristina K. Peachman
  • Leonid Margolis
  • Luca Schifanella
  • Mangala Rao
  • Manuel Becerra-flores
  • Margaret Beddall
  • Margherita Rosati
  • Marina Tuyishime
  • Mario Roederer
  • Marjorie Robert-Guroff
  • Massimiliano Bissa
  • Matthew Breed
  • Mei-hue Liu
  • Melvin N. Doster
  • Michael A Eller
  • Michael Read
  • Mohammad Arif Rahman
  • Mohammed S. Ahmadi
  • Monica Vaccari
  • Namal P M Liyanage
  • Peter D. Kwong
  • Raffaello Verardi
  • Richard Nguyen
  • Rosemarie Mason
  • Sarkis Sarkis
  • Stephen Whitney
  • Susie Min
  • Timothy J. Cardozo
  • Veronica Galli
  • William Magnanelli
  • Xiaoying Shen
  • Zhanna Shubin

Organizations

  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases
  • National Institute on Drug Abuse
  • Office of AIDS Research
  • U.S. Military HIV Research Program
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology